Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
URGNthis companyUroGen Pharma Ltd.	$26.33	-7.34×	-10.68×	10.26×	-8.44×	-186.4%	88.7%	-113.7%	-139.8%	145.5%	-81.1%	-14.4%	-1.22×	-0.13×	-3.69×	4.01×	0.0%	2	-2.29	2	C
CGONCG Oncology Inc.	$75.45	-19.96×	4.26×	794.47×	-19.96×	-105.2%	-15.0%	-4722.1%	-3985.0%	-21.4%	-25.0%	-4.1%	0.01×	0.16×	0×	24.63×	0.0%	3	58.05	1	C-
RLMDRelmada Therapeutics, Inc.	$4.12	-3.33×	2.2×	0×	-3.26×	-98.7%	0.0%	0.0%	0.0%	-66.3%	-67.5%	-24.0%	0×	0.06×	0×	14.62×	0.0%	2	13.25	1	C-
Peer median	—	-11.65×	3.23×	397.23×	-11.61×	-102.0%	-7.5%	-2361.1%	-1992.5%	-43.9%	-46.3%	-14.1%	0×	0.11×	0×	19.62×	0.0%	3	35.65	1	—